We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Ribbon Communications
RBBN
$383M
| $422K | ﹤0.01% |
157,492
-3,701
| -2% | -$10.8K |
|
2627
Arcutis Biotherapeutics
ARQT
$3.18B
| $422K | ﹤0.01% |
79,430
+878
| +1% | +$7.47K |
|
|
STKL
2628
DELISTED
SunOpta
STKL
| $421K | ﹤0.01% |
125,056
-910
| -0.7% | -$4.56K |
|
|
ARIS
2629
DELISTED
Aris Water Solutions
ARIS
| $421K | ﹤0.01% |
42,174
+144
| +0.3% | +$1.53K |
|
2630
Rayonier Advanced Materials
RYAM
$610M
| $419K | ﹤0.01% |
118,372
-2,542
| -2% | -$9.54K |
|
2631
Intrepid Potash
IPI
$469M
| $419K | ﹤0.01% |
16,653
-344
| -2% | -$8.81K |
|
2632
SEACOR Marine Holdings
SMHI
$258M
| $418K | ﹤0.01% |
30,123
+4,175
| +16% | +$50.7K |
|
2633
Entrada Therapeutics
TRDA
$267M
| $418K | ﹤0.01% |
26,449
+2,230
| +9% | +$35.1K |
|
2634
Aldeyra Therapeutics
ALDX
$93.5M
| $418K | ﹤0.01% |
62,512
+3,018
| +5% | +$22.4K |
|
|
GPMT
2635
Granite Point Mortgage Trust
GPMT
$61.2M
| $417K | ﹤0.01% |
85,521
-1,029
| -1% | -$5.53K |
|
2636
Playtika
PLTK
$1.12B
| $417K | ﹤0.01% |
43,290
-10,238
| -19% | -$110K |
|
2637
Solid Power
SLDP
$532M
| $416K | ﹤0.01% |
206,187
-6,750
| -3% | -$16K |
|
2638
iShares MSCI Switzerland ETF
EWL
$2.25B
| $415K | ﹤0.01% |
9,530
-4,350
| -31% | -$200K |
|
2639
Limbach Holdings
LMB
$581M
| $415K | ﹤0.01% |
13,074
+2,266
| +21% | +$68.6K |
|
2640
Hingham Institution for Saving
HIFS
$663M
| $415K | ﹤0.01% |
2,221
+9
| +0.4% | +$1.84K |
|
2641
PLAYSTUDIOS Inc
MYPS
$90.1M
| $412K | ﹤0.01% |
129,487
+1,796
| +1% | +$7.13K |
|
2642
Universal Technical Institute
UTI
$1.59B
| $412K | ﹤0.01% |
49,108
-156
| -0.3% | -$1.22K |
|
|
AXIA
2643
DELISTED
AXIA Energia
AXIA
| $411K | ﹤0.01% |
70,945
+12,229
| +21% | +$72.7K |
|
2644
MaxCyte
MXCT
$126M
| $410K | ﹤0.01% |
131,408
-91
| -0.1% | -$366 |
|
|
SHCR
2645
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $410K | ﹤0.01% |
436,059
-874
| -0.2% | -$1.04K |
|
|
SHI
2646
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $410K | ﹤0.01% |
22,415
| – | – |
|
2647
Cullinan Oncology
CGEM
$1.14B
| $409K | ﹤0.01% |
45,239
-988
| -2% | -$10.3K |
|
2648
Ocular Therapeutix
OCUL
$2.02B
| $408K | ﹤0.01% |
130,016
+7,793
| +6% | +$31.9K |
|
2649
Destination XL Group
DXLG
$35.4M
| $408K | ﹤0.01% |
90,986
+206
| +0.2% | +$967 |
|
2650
PetMed Express
PETS
$42.3M
| $405K | ﹤0.01% |
39,499
-54,570
| -58% | -$673K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.